NAGE compared with MFIN: revenue, margins and what each company keeps, and the suppliers and customers both name

NAGENiagen Bioscience, Inc.

Mkt capRevenueRevenue

MFINMedallion Financial Corp

Mkt capRevenueRevenue

Compare

NAGENiagen Bioscience, Inc.

MFINMedallion Financial Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

NAGEwithMFIN

×0.10co-movement · MFIN on NAGE · 499d

r 0.27scale to r 0.75

No shared co-movers.

NAGE, solidMFIN, hatched× = co-movement · βr = correlationBar = r to r 0.75Source: daily closes

NAGENiagen Bioscience, Inc.

2.11▼−16.27%· post 2.11· delayed

Mkt cap$199.4MRevenue$27MQ3 FY26Revenue$129MFY25

MFINMedallion Financial Corp

10.05▼−3.09%· post 10.05· delayed

After hoursNov 5 '26delayed

Mkt cap$238.1MRevenue$62MQ2 FY26Revenue$248MFY25

Compare

After hoursNov 5 '26delayed

NAGENiagen Bioscience, Inc.

MFINMedallion Financial Corp

2.11▼−16.27%post 2.11delayed

Price

10.05▼−3.09%post 10.05delayed

$199.4M

Mkt cap

$238.1M

Q3 FY26$27M

Revenue

$62MQ2 FY26

FY25$129M

Revenue

$248MFY25

NAGE2.11▼−16.27%vsMFIN10.05▼−3.09%After hoursNov 5 '26delayed